1. Clinical utility of pretreatment prediction of chemoradiotherapy response in rectal cancer: a review
   Byong Chul Yoo et al, 2017, EPMA Journal CrossRef
2. Current Status of the Watch-and-Wait Policy for Patients with Complete Clinical Response Following Neoadjuvant Chemoradiation in Rectal Cancer
   Rob Glynne-Jones et al, 2017, Current Colorectal Cancer Reports CrossRef
3. Factors associated with low anterior resection syndrome after surgical treatment of rectal cancer
   L. M. Jimenez‐Gomez et al, 2018, Colorectal Disease CrossRef
4. Complete radiotherapy response in rectal cancer: A review of the evidence
   Daniel G Couch, 2016, World Journal of Gastroenterology CrossRef
5. Seven low-mass ions in pretreatment serum as potential predictive markers of the chemoradiotherapy response of rectal cancer
   Kangsan Roh et al, 2016, Anti-Cancer Drugs CrossRef
6. Complete Response after Chemoradiotherapy in Rectal Cancer (Watch-and-Wait): Have we Cracked the Code?
   R. Glynne-Jones et al, 2016, Clinical Oncology CrossRef
7. How Should a Multi-disciplinary Team (MDT) Approach the Issue of Non-Operative Management in Rectal Cancer?
   null null et al, 2015, Current Colorectal Cancer Reports CrossRef
8. Association of pretreatment serum carcinoembryonic antigen levels with chemoradiation-induced downstaging and downsizing of rectal cancer
   SEUNG-GU YEO, 2016, Molecular and Clinical Oncology CrossRef
9. Surveillance after curative treatment for colorectal cancer
   Eric P. van der Stok et al, 2017, Nature Reviews Clinical Oncology CrossRef